{{Rsnum
|rsid=1151640
|Gene=OR13G1
|Chromosome=1
|position=247672648
|Orientation=minus
|ReferenceAllele=A
|MissenseAllele=G
|GMAF=0.4394
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=OR13G1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 28.3 | 51.3 | 20.4
| HCB | 14.6 | 41.6 | 43.8
| JPT | 11.5 | 51.3 | 37.2
| YRI | 73.5 | 25.9 | 0.7
| ASW | 61.4 | 36.8 | 1.8
| CHB | 14.6 | 41.6 | 43.8
| CHD | 22.9 | 46.8 | 30.3
| GIH | 36.6 | 49.5 | 13.9
| LWK | 79.1 | 19.1 | 1.8
| MEX | 8.8 | 56.1 | 35.1
| MKK | 60.3 | 37.8 | 1.9
| TSI | 29.4 | 57.8 | 12.7
| HapMapRevision=28
}}rs1151640 increases susceptibility to Myocardial Infarction 1.31 times for heterozygotes (AG) and 1.40 times for homozygotes (GG) {{PMID|16175505|OA=1
}}

An independent study of 3657 patients with myocardial infarction (885 women and 2772 men) and 1211 control individuals (598 women and 613 men) did not observe any correlation to this SNP.{{PMID|19709766}}

{{PMID Auto
|PMID=18599554
|Title=Replication study of 10 genetic polymorphisms associated with coronary heart disease in a specific high-risk population with familial hypercholesterolemia.
|OA=1
}}

{{PMID Auto
|PMID=20017983
|Title=Evaluation of population impact of candidate polymorphisms for coronary heart disease in the Framingham Heart Study Offspring Cohort.
|OA=1
}}

{{GET Evidence
|gene=OR13G1
|aa_change=Ile132Val
|aa_change_short=I132V
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1151640
|overall_frequency_n=3607
|overall_frequency_d=10758
|overall_frequency=0.335285
|n_genomes=31
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=0
|n_articles_annotated=0
|nblosum100=-4
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}